Prognostic Value of the 6-minute Stepper Test in Non-small Cell Lung Cancer Surgery

Completed

• Conditions: Resectable Lung Non-Small Cell Carcinoma; Lung Neoplasm Malignant

• Registration Number: NCT03824977
• Lead Sponsor: University Hospital, Rouen

Brief Summary

The objective of this study is to evaluate the performances of the Six-Minute Stepper Test (6MST) and Sit To Stand test (STST) to predict post-operative complications after minimally invasive lung cancer resection.

Detailed Description

Not available

Study Timeline

• Study Start: 2018-11-21
• Study First Submitted: 2019-01-29
• Study First Submitted QC: 2019-01-29
• Study First Posted: 2019-01-31
• Primary Completion: 2020-02-04
• Study Completion: 2020-02-04
• Status Verified: 2022-02
• Last Update Submitted: 2022-02-18
• Last Update Posted: 2022-03-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 122

Inclusion Criteria

• Age >18
• Non-small cell lung cancer stage I to II, justifying major resection by VATS or RATS (segmentectomy, lobectomy, pneumonectomy), with or without histological confirmation

Exclusion Criteria

• Partial or total amputation localized to the lower limb;
• Weight greater than 100 kg;
• Orthopedic, vascular or neurological disorders leading to the incapacity of realize the 6MST;
• Patient under tutorship or curatorship;
• Pregnant woman.
• Surgery canceled

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
occurrence of a post-operative complication grade ≥ 2 on the Clavien-Dindo scale within three months after surgery	90 days

Trial Locations

Locations (1)

Boujibar , F; 🇫🇷 Rouen, France